- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00886912
Training in Hypoxia to Prevent Acute Mountain Sickness
June 24, 2010 updated by: Heidelberg University
Prevention of Acute Mountain Sickness (AMS) by Intermittent Hypoxic Training
Some studies suggest that high-altitude related illnesses - like acute mountain sickness - could be prevented by acclimatisation, reached at low altitude using training in simulated altitude.
The purpose of this study is to determine whether training in hypoxia is suitable to prevent acute mountain sickness.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
In a three week-period, healthy probands undergo 3 times a week a bicycle ergometer training in simulated altitude followed by 1 week passive exposure at simulated low altitude.
5 days after last exposure, a field study starts performing a rapid ascent to the Capanna Regina Margherita (4559m).
Acute mountain sickness is assessed by established scoring systems.
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Heidelberg, Germany, 69120
- Recruiting
- Departement of Sports Medicine, University of Heidelberg
-
Contact:
- Kai Schommer, MD
- Phone Number: +49 (0)6221 568256
- Email: kai.schommer@med.uni-heidelberg.de
-
Contact:
- Peter Bärtsch, MD
- Phone Number: +49 (0)6221 268101
- Email: peter.baertsch@med.uni-heidelberg.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy
- non-smoker
- endurance training min. 2x/week
Exclusion Criteria:
- any diseases
- previous exposure to altitudes higher than 2000m (last 6 weeks)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Hypoxia
training in simulated altitude
|
training in simulated altitude in a hypoxic chamber (normobaric hypoxia)
|
|
Placebo Comparator: Normoxia
training under normoxic conditions
|
training under normoxic conditions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of acute mountain sickness
Time Frame: after 20 hours at 4559m
|
after 20 hours at 4559m
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Severity of acute mountain sickness
Time Frame: after 20 hours at 4559m
|
after 20 hours at 4559m
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kai Schommer, MD, Departement of Sports Medicine, University of Heidelberg
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2008
Primary Completion (Actual)
August 1, 2008
Study Completion (Anticipated)
October 1, 2009
Study Registration Dates
First Submitted
April 21, 2009
First Submitted That Met QC Criteria
April 22, 2009
First Posted (Estimate)
April 23, 2009
Study Record Updates
Last Update Posted (Estimate)
June 25, 2010
Last Update Submitted That Met QC Criteria
June 24, 2010
Last Verified
April 1, 2009
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- S-160/2008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.